Drugs News and Research

RSS

EMA designates allopurinol as first orphan drug for the treatment of Marfan syndrome

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date.

19 May 2025

Common anti-inflammatory drugs may aid virus spread

New research shows an unintended and unfortunate side effect of common drugs. They can simply help viruses spread.

19 May 2025

Evolution of malaria protein family offers new drug targets

Researchers from the Francis Crick Institute and the Gulbenkian Institute for Molecular Medicine (GIMM) have shown that the evolution of a family of exported proteins in the malaria-causing parasite Plasmodium falciparum enabled it to infect humans.

19 May 2025

World's first-in-human bladder transplant marks milestone in urologic surgery

Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant.

18 May 2025

High cost of immunotherapy linked to financial hardship among cancer survivors

A study published today in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy treatments were more likely to face financial hardship, leading to increased instances of being unable to afford care and taking fewer medications due to cost.

18 May 2025

Study reveals how acetaminophen may actually relieve pain

A new study from Indiana University scientists may aid the pharmaceutical industry in better understanding a popular over-the-counter pain reliever: Tylenol.

16 May 2025

Immune checkpoint inhibitors linked to increased myocarditis risk in lung cancer patients

A new editorial was published in Volume 12 of Oncoscience on May 2, 2025, titled "Immune checkpoint inhibitors and myocarditis: Lessons from a nationwide cohort study."

16 May 2025

Clinical trial against breast cancer explores the potential anti-tumor role of denosumab

Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where basic researchers, clinicians and patients are involved, as shown by the initial results of D-BIOMARK.

16 May 2025

Targeting PME-1 may offer new strategies for treating neurological disorders and cancer

PME-1 is a protein that modifies other proteins by removing methyl groups, but high levels of PME-1 are observed in some diseases, including Alzheimer's disease (AD) and cancer.

16 May 2025

Pharmacists stockpile most common drugs on chance of targeted Trump tariffs

In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one man's defensive wall in a tariff war.

16 May 2025

Aptamer announces new data at ASGCT

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans, LA (13-17 May 2025).

From Aptamer Group 16 May 2025

$Discovery of mutated immune cell clones could point to improved treatment for refractory celiac disease$

Discovery of mutated immune cell clones could point to improved treatment for refractory celiac disease

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.

15 May 2025

Astrocytes found to drive brain rewiring during attention states

Researchers at Washington University School of Medicine in St. Louis have upended decades-old dogma of how connections between brain cells are rearranged during states of heightened vigilance or attention.

15 May 2025

Targeting brain neurons to successfully treat type 2 diabetes

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a study published today in the Journal of Clinical Investigation.

15 May 2025

New gene editor evoCAST enables precise insertion of complete genes

Ask scientists what gene editing tool is most needed to advance gene therapy, and they'd probably describe a system that's now close to realization in the labs of Samuel Sternberg at Columbia University Vagelos College of Physicians and Surgeons and David Liu at the Broad Institute of MIT and Harvard.

15 May 2025

Breakthrough bat organoid platform sheds light on behavior of zoonotic viruses

Did you know that more than 75% of new infectious diseases affecting humans originally come from animals? Bats, in particular, are natural hosts to some of the world's most dangerous viruses, including those responsible for COVID-19 (SARS-CoV-2), MERS-CoV, influenza A, and hantavirus outbreaks.

15 May 2025

KFF Health News' 'What the Health?': GOP poised to cut billions in health benefits

After all-night markups, two key House committees approved GOP budget legislation that would cut hundreds of billions of dollars from federal health programs over the next decade, mostly from the Medicaid program for people with low incomes or disabilities.

15 May 2025

Ubrogepant relieves early migraine symptoms and may help prevent full-blown attacks

A phase 3 trial found that ubrogepant, given during the premonitory phase of migraine, improved common warning symptoms such as fatigue, light and sound sensitivity, and neck pain. These benefits were observed as early as one hour post-treatment, suggesting early intervention can reduce migraine burden.

15 May 2025

Pain clinic CEO faced 20 years for making patients ‘human pin cushions.’ He got 18 months.

Federal prosecutors sought a maximum prison sentence of nearly 20 years for the CEO of Pain MD, a company found to have given hundreds of thousands of questionable injections to patients, many reliant on opioids.

15 May 2025

Revolutionary incision-free technique halts growth of brain cavernomas

A new, incision-free technique developed at UVA Health to treat debilitating brain lesions called cerebral cavernous malformations, or cavernomas, has shown great promise in early testing, halting the growth of the lesions almost entirely.

15 May 2025

Drugs News and Research

EMA designates allopurinol as first orphan drug for the treatment of Marfan syndrome

Common anti-inflammatory drugs may aid virus spread

Evolution of malaria protein family offers new drug targets

World's first-in-human bladder transplant marks milestone in urologic surgery

High cost of immunotherapy linked to financial hardship among cancer survivors

Study reveals how acetaminophen may actually relieve pain

Immune checkpoint inhibitors linked to increased myocarditis risk in lung cancer patients

Clinical trial against breast cancer explores the potential anti-tumor role of denosumab

Targeting PME-1 may offer new strategies for treating neurological disorders and cancer

Pharmacists stockpile most common drugs on chance of targeted Trump tariffs

Aptamer announces new data at ASGCT

Discovery of mutated immune cell clones could point to improved treatment for refractory celiac disease

Astrocytes found to drive brain rewiring during attention states

Targeting brain neurons to successfully treat type 2 diabetes

New gene editor evoCAST enables precise insertion of complete genes

Breakthrough bat organoid platform sheds light on behavior of zoonotic viruses

KFF Health News' 'What the Health?': GOP poised to cut billions in health benefits

Ubrogepant relieves early migraine symptoms and may help prevent full-blown attacks

Pain clinic CEO faced 20 years for making patients ‘human pin cushions.’ He got 18 months.

Revolutionary incision-free technique halts growth of brain cavernomas

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News